Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have covered the stock in the last year […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The […]
Dynatrace (NYSE:DT – Free Report) had its target price lowered by Wells Fargo & Company from $75.00 to $60.00 in a report released on Thursday, Benzinga reports. The firm currently has an overweight rating on the stock. Other equities analysts also recently issued research reports about the company. Royal Bank of Canada lowered their price […]
Adagene Inc. (NASDAQ:ADAG – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase of 6.3% from the April 15th total of 14,200 shares. Based on an average daily volume of 25,400 shares, the […]
KE Holdings Inc. (NYSE:BEKE – Get Free Report) saw unusually large options trading on Thursday. Stock investors purchased 19,185 call options on the company. This represents an increase of 36% compared to the average daily volume of 14,106 call options. Hedge Funds Weigh In On KE A number of hedge funds have recently modified their […]